Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Notice when it drops, and keep simple movement habits going on lower-energy days
Because of the ever-expanding use of GLP-1 receptor agonists, the availability of an oral agent within this therapeutic class has the potential to further increase GLP-1 receptor agonist use and provide an alternative route of administration for patients unable or unwilling to take SC injections
Click the button to explore savings offers
Cagrilintide is an investigational compound with no approval from the FDA or any other regulator, and is sold for laboratory research use only
:format(webp))
US$ 27.64
US$ 27.46
US$ 28.87
